Martin Philpott

Frapid: achieving full automation of FRAP for chemical probe validation.

Clarence Yapp, Catherine Rogers, Pavel Savitsky, 2016, Biomedical optics express.

Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain

Chris Abell, Stefan Knapp, Frank von Delft, 2013, Journal of medicinal chemistry.

A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation–π Interaction**

Stefan Knapp, Robert S Paton, Susanne Müller, 2014, Angewandte Chemie.

Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B

Lewis R. Vidler, Stefan Knapp, Susanne Müller, 2015, Journal of medicinal chemistry.

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B

Stefan Knapp, Susanne Müller, Chun-Wa Chung, 2015, Journal of medicinal chemistry.

Dietary cancer and prevention using antimutagens.

Martin Philpott, L. Ferguson, M. Philpott, 2004, Toxicology.